136 related articles for article (PubMed ID: 37661653)
1. Improvement of objective ocular redness measured with Keratograph 5M in glaucoma patients after instilling brimonidine drops.
Montolío-Marzo E; Fernández-Narros R; Morales-Fernández L; García-Bella J; Sáenz-Francés F; García-Feijoo J; Martínez-de-la-Casa JM
Eur J Ophthalmol; 2024 Mar; 34(2):480-486. PubMed ID: 37661653
[TBL] [Abstract][Full Text] [Related]
2. Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops.
Pérez Bartolomé F; Martínez de la Casa JM; Arriola Villalobos P; Fernández Pérez C; Polo V; Sánchez Jean R; García Feijoó J
Semin Ophthalmol; 2018; 33(5):643-650. PubMed ID: 29144869
[TBL] [Abstract][Full Text] [Related]
3. Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues.
El Ameen A; Vandermeer G; Khanna RK; Pisella PJ
Eur J Ophthalmol; 2019 Nov; 29(6):645-653. PubMed ID: 30301370
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial.
Kim KE; Lee CK; Shin J; Kim Y; Rho S
Sci Rep; 2023 Apr; 13(1):5700. PubMed ID: 37029145
[TBL] [Abstract][Full Text] [Related]
5. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma.
Pérez-Bartolomé F; Martínez-de-la-Casa JM; Arriola-Villalobos P; Fernández-Pérez C; Polo V; García-Feijoó J
Eur J Ophthalmol; 2017 Nov; 27(6):694-704. PubMed ID: 28497458
[TBL] [Abstract][Full Text] [Related]
6. Preservative-free
Duru Z; Ozsaygili C
Cutan Ocul Toxicol; 2020 Mar; 39(1):21-24. PubMed ID: 31615279
[No Abstract] [Full Text] [Related]
7. Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine.
Tanihara H; Yamamoto T; Aihara M; Koizumi N; Minami H; Kojima S; Isobe T; Kanazawa M; Suganami H;
Adv Ther; 2023 Aug; 40(8):3559-3573. PubMed ID: 37330927
[TBL] [Abstract][Full Text] [Related]
8. Intraocular light scatter in patients on topical intraocular pressure-lowering medication.
Pérez-Bartolomé F; Martínez de la Casa JM; Arriola-Villalobos P; Fernández-Pérez C; García-Feijoó J
Eur J Ophthalmol; 2018 Nov; 28(6):652-661. PubMed ID: 29631441
[TBL] [Abstract][Full Text] [Related]
9. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
Wu JH; Wang TH; Huang JY; Su CC
J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
[No Abstract] [Full Text] [Related]
10. Assessment of ocular redness measurements obtained with keratograph 5M and correlation with subjective grading scales.
Pérez-Bartolomé F; Sanz-Pozo C; Martínez-de la Casa JM; Arriola-Villalobos P; Fernández-Pérez C; García-Feijoó J
J Fr Ophtalmol; 2018 Nov; 41(9):836-846. PubMed ID: 30293826
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis.
Portela RC; Fares NT; Machado LF; São Leão AF; de Freitas D; Paranhos A; Prata TS; Gracitelli CPB
J Glaucoma; 2018 Sep; 27(9):794-801. PubMed ID: 29916999
[TBL] [Abstract][Full Text] [Related]
12. Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis.
Fares NT; Portela RC; Machado LF; Polizelli M; Freitas D; Paranhos A; Prata TS; Gracitelli CPB
Arq Bras Oftalmol; 2021; 84(4):345-351. PubMed ID: 33567039
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications.
Giannaccare G; Pellegrini M; Bernabei F; Senni C; Aloi M; Scalzo GC; Ceravolo D; Iovino C; Scorcia V
Eur J Ophthalmol; 2021 Sep; 31(5):2405-2411. PubMed ID: 33148017
[TBL] [Abstract][Full Text] [Related]
14. Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy.
Lee JS; Kim CY
Expert Rev Clin Pharmacol; 2022 Aug; 15(8):911-919. PubMed ID: 35951740
[TBL] [Abstract][Full Text] [Related]
15. Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis.
Harasymowycz P; Hutnik C; Rouland JF; Negrete FJM; Economou MA; Denis P; Baudouin C
Adv Ther; 2021 Jun; 38(6):3019-3031. PubMed ID: 33891269
[TBL] [Abstract][Full Text] [Related]
16. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
[TBL] [Abstract][Full Text] [Related]
17. Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.
Inatani M; Orii Y; Iwasaki K; Arimura S; Sunagawa H; Shiokawa M; Inoue K; Sakono T; Sakono T; Kuwamura R; Yoshida A; Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Manabe K; Tanito M
Adv Ther; 2023 Sep; 40(9):4074-4092. PubMed ID: 37452961
[TBL] [Abstract][Full Text] [Related]
18. Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial.
McLaurin E; Cavet ME; Gomes PJ; Ciolino JB
Optom Vis Sci; 2018 Mar; 95(3):264-271. PubMed ID: 29461408
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study.
Su CC; Lee YC; Lee PRC
Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1243-1251. PubMed ID: 33433642
[TBL] [Abstract][Full Text] [Related]
20. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.
Lusthaus JA; Goldberg I
Expert Opin Drug Saf; 2017 Sep; 16(9):1071-1078. PubMed ID: 28656780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]